PIM2 抗体
Recommended next Filters:
您想试用我们的人工智能搜索吗?
56 results :
Latest Publications for our PIM2 抗体
: "PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma." in: British journal of cancer, Vol. 107, Issue 3, pp. 491-500, (2012) (PubMed).: "Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion." in: Molecular cancer, Vol. 9, pp. 279, (2010) (PubMed).
: "Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels." in: Cancer research, Vol. 68, Issue 13, pp. 5076-85, (2008) (PubMed).
: "Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity." in: Cancer research, Vol. 67, Issue 14, pp. 6916-24, (2007) (PubMed).
: "Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation." in: Cancer research, Vol. 64, Issue 22, pp. 8341-8, (2004) (PubMed).
Aliases for PIM2 抗体
Pim-2 proto-oncogene, serine/threonine kinase (pim2) 抗体Pim-2 proto-oncogene, serine/threonine kinase (PIM2) 抗体
Pim-2 proto-oncogene, serine/threonine kinase (Pim2) 抗体
proviral integration site 2 (Pim2) 抗体
cb1068 抗体
DXCch3 抗体
fj47b05 抗体
Pim-2 抗体
pim2 抗体
wu:fj47b05 抗体